Literature DB >> 28224967

Time to be positive about negative data?

T Vincent1, A-M Malfait2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28224967      PMCID： PMC6034630          DOI： 10.1016/j.joca.2017.01.016

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN： 1063-4584            Impact factor:   6.576


× No keyword cloud information.
  16 in total

1.  ADAMTS-5 takes centre stage in new developments for aggrecanase inhibitors.

Authors:  A J Fosang
Journal:  Osteoarthritis Cartilage       Date:  2015-05-28       Impact factor: 6.576

Review 2.  Considerations for the design and execution of protocols for animal research and treatment to improve reproducibility and standardization: "DEPART well-prepared and ARRIVE safely".

Authors:  M M Smith; E C Clarke; C B Little
Journal:  Osteoarthritis Cartilage       Date:  2016-11-02       Impact factor: 6.576

3.  ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.

Authors:  Chris B Little; Laureane Mittaz; Daniele Belluoccio; Fraser M Rogerson; Ian K Campbell; Clare T Meeker; John F Bateman; Melanie A Pritchard; Amanda J Fosang
Journal:  Arthritis Rheum       Date:  2005-05

4.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.

Authors:  Heather Stanton; Fraser M Rogerson; Charlotte J East; Suzanne B Golub; Kate E Lawlor; Clare T Meeker; Christopher B Little; Karena Last; Pamela J Farmer; Ian K Campbell; Anne M Fourie; Amanda J Fosang
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

5.  Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice.

Authors:  Atsushi Fukai; Satoru Kamekura; Daichi Chikazu; Takumi Nakagawa; Makoto Hirata; Taku Saito; Yoko Hosaka; Toshiyuki Ikeda; Kozo Nakamura; Ung-il Chung; Hiroshi Kawaguchi
Journal:  Arthritis Rheum       Date:  2012-01

Review 6.  In vivo osteoarthritis target validation utilizing genetically-modified mice.

Authors:  Sonya S Glasson
Journal:  Curr Drug Targets       Date:  2007-02       Impact factor: 3.465

7.  Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice.

Authors:  Sonya S Glasson; Roger Askew; Barbara Sheppard; Brenda A Carito; Tracey Blanchet; Hak-Ling Ma; Carl R Flannery; Kim Kanki; Eunice Wang; Diane Peluso; Zhiyong Yang; Manas K Majumdar; Elisabeth A Morris
Journal:  Arthritis Rheum       Date:  2004-08

8.  Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.

Authors:  Kristen M Clements; Joanne S Price; Mark G Chambers; Denise M Visco; A Robin Poole; Roger M Mason
Journal:  Arthritis Rheum       Date:  2003-12

9.  Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.

Authors:  S C M van Dalen; A B Blom; A W Slöetjes; M M A Helsen; J Roth; T Vogl; F A J van de Loo; M I Koenders; P M van der Kraan; W B van den Berg; M H J van den Bosch; P L E M van Lent
Journal:  Osteoarthritis Cartilage       Date:  2016-09-18       Impact factor: 6.576

10.  Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis.

Authors:  Manas K Majumdar; Roger Askew; Scott Schelling; Nancy Stedman; Tracey Blanchet; Bei Hopkins; Elisabeth A Morris; Sonya S Glasson
Journal:  Arthritis Rheum       Date:  2007-11
View more
  2 in total

Review 1.  Molecular and structural imaging in surgically induced murine osteoarthritis.

Authors:  N H Lim; C Wen; T L Vincent
Journal:  Osteoarthritis Cartilage       Date:  2020-04-16       Impact factor: 6.576

Review 2.  IL-1 in osteoarthritis: time for a critical review of the literature.

Authors:  Tonia L Vincent
Journal:  F1000Res       Date:  2019-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.